178
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Oral Prevalence of Candida Species in Patients Undergoing Systemic Glucocorticoid Therapy and the Antifungal Sensitivity of the Isolates

, , ORCID Icon, ORCID Icon, & ORCID Icon
Pages 2601-2607 | Published online: 29 Jul 2020

References

  • Badiee P, Kordbacheh P, Alborzi A, et al. Fungal infections in solid organ recipients. Exp Clin Transplant. 2005;3(2):385–389.16417449
  • Singh A, Verma R, Murari A, Agrawal A. Oral candidiasis: an overview. J Oral Maxillofac Pathol. 2014;18(Suppl 1):S81–S855. doi:10.4103/0973-029X.14132525364186
  • Rachelefsky GS, Liao Y, Faruqi R. Impact of inhaled corticosteroid-induced oropharyngeal adverse events: results from a meta-analysis. Ann Allergy Asthma Immunol. 2007;98(3):225–238. doi:10.1016/S1081-1206(10)60711-917378253
  • Farhan MA, Moharram AM, Salah T, Shaaban OM. Types of yeasts that cause vulvovaginal candidiasis in chronic users of corticosteroids. Med Myco. 2019;57(6):681–687. doi:10.1093/mmy/myy117
  • Patil S, Rao RS, Majumdar B, et al. Clinical appearance of oral Candida infection and therapeutic strategies. Front Microbiol. 2015;6:1391. doi:10.3389/fmicb.2015.0139126733948
  • Samaranayake LP, MacFarlane TW, Lamey PJ, et al. A comparison of oral rinse and imprint sampling techniques for the detection of yeast, coliform and Staphylococcus aureus carriage in the oral cavity. J Oral Pathol. 1986;15(7):386–388. doi:10.1111/j.1600-0714.1986.tb00646.x3098945
  • Tooyama H, Matsumoto T, Hayashi K, et al. Candida concentrations determined following concentrated oral rinse culture reflect clinical oral signs. BMC Oral Health. 2015;15:150. doi:10.1186/s12903-015-0138-z26597294
  • Leaw SN, Chang HC, Sun HF, et al. Identification of medically important yeast species by sequence analysis of the internal transcribed spacer regions. J Clin Microbiol. 2006;44(3):693–699. doi:10.1128/JCM.44.3.693-699.200616517841
  • Li Y, Xiao J, De Hoog GS, et al. Biodiversity and human-pathogenicity of Phialophora verrucosa and relatives in Chaetothyriales. Mol Phylogen Evol Fungi. 2017;38:1–19. doi:10.3767/003158517X692779
  • Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts Approved Standard-Third Edition. CLSI Document M27-A3. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
  • Clinical and Laboratory Standards Institute. Performance Standards for Antifungal Susceptibility Testing of Yeasts. 1st ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2017.
  • Clinical and Laboratory Standards Institute. Epidemiological Cutoff Values for Antifungal Susceptibility Testing. 2nd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2018.
  • Pfaller MA, Diekema DJ. Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012. J Clin Microbiol. 2012;50(9):2846–2856. doi:10.1128/JCM.00937-1222740712
  • Pakshir K, Ghasemi N, Zomorodian K, et al. Identification and antifungal activity profile of Candida species isolated from patients with pemphigus vulgaris with oral lesions. Acta Dermatovenerol Croat. 2019;27(3):137–141.31542055
  • Al-Attas SA, Amro SO. Candidal colonization, strain diversity, and antifungal susceptibility among adult diabetic patients. Ann Saudi Med. 2010;30(2):101–108. doi:10.4103/0256-4947.60514.20220258
  • Keerthi M, Reddy GS, Shekar PC, et al. A study on isolation, identification, and antifungal susceptibility of various oral candidal species in renal transplant patients. J NTR Univ Health Sci. 2015;4(3):170–175. doi:10.4103/2277-8632.165399
  • Yan Z, Young AL, Hua H, Xu Y. Multiple oral Candida infections in patients with Sjögren’s syndrome-prevalence and clinical and drug susceptibility profiles. J Rheumatol. 2011;38(11):2428–2431. doi:10.3899/jrheum.10081921844143
  • Genco RJ, Borgnakke WS. Risk factors for periodontal disease. Periodontology. 2000;62(1):59–94. doi:10.1111/j.1600-0757.2012.00457.x
  • Hassanpour K, Tehrani H, Goudarzian M, et al. Comparison of the frequency of dental caries in asthmatic children under treatment with inhaled corticosteroids and healthy children in Sabzevar in 2017–2018. Electron J Gen Med. 2019;16(2):em119. doi:10.29333/ejgm/93478
  • Terézhalmy GT, Huber MA. Oropharyngeal candidiasis: etiology, epidemiology, clinical manifestations, diagnosis, and treatment. Crest Oral-B at dentalcare. Contin Educ Course. 2011;1–16.
  • Dangi YS, Soni ML, Namdeo KP. Oral candidiasis: a review. Int J Pharm Pharm Sci. 2010;2(4):36–41.
  • Henriksen DP, Davidsen JR, Christiansen A, et al. Inhaled corticosteroids and systemic or topical antifungal therapy: a symmetry analysis. Ann Am Thorac Soc. 2017;14(6):1045–1047. doi:10.1513/AnnalsATS.201612-1043LE28570158
  • Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America. Clin Infect Dis. 2016;62(4):e1–50. doi:10.1093/cid/civ93326679628
  • Črešnar B, Žakelj-Mavrič M. Aspects of the steroid response in fungi. Chem Biol Interact. 2009;178(1–3):303–309. doi:10.1016/j.cbi.2008.11.00219046956
  • Pfaller MA, Diekema DJ, Gibbs DL, et al. Results from the ARTEMIS DISK global antifungal surveillance study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J Clin Microbiol. 2010;48(4):1366–1377. doi:10.1128/JCM.02117-0920164282